Pour une version Française, cliquez ici.
Cyprotex have received confirmation from the French Ministry of Research (Ministère de l’Enseignement Supérieur et de la Recherche) that it has been approved as a company eligible for performing services under the French Research Tax Credit initiative. Cyprotex was first awarded eligibility for this scheme in 2009 and the current agreement extends the arrangement for another 3 years until the end of 2017. Under the French Research Tax Credit (Crédit Impôt Recherche – CIR), eligible French pharmaceutical, biotech, cosmetic and agricultural companies that a subject to the corporate tax can claim relief on costs incurred in Research and Development performed by Cyprotex.
Cyprotex works with many French clients of varying sizes and industries. By being part of the French Research Tax Credit scheme, Cyprotex attracts business from France and allows French customers to significantly benefit financially from working with Cyprotex.
To request a copy of our French Research Tax Credit Eligibility Certificate, please contact us on email@example.com